Mechanism of transduction by retroviruses.

Retroviruses can capture cellular sequences and express them as oncogenes. Capture has been proposed to be a consequence of the inefficiency of polyadenylation of the viral genome that allows the packaging of cellular sequences flanking the integrated provirus in virions; after transfer into virions, these sequences could be incorporated into the viral genome by illegitimate recombination during reverse transcription. As a test for this hypothesis, a tissue culture system was developed that mimics the transduction process and allows the analysis and quantitation of capture events in a single step. In this model, transduction of sequences adjacent to a provirus depends on the formation of readthrough transcripts and their transmission in virions and leads to various recombinant structures whose formation is independent of sequence similarity at the crossover site. Thus, all events in the transduction process can be attributed to the action of reverse transcriptase on readthrough transcripts without involving deletions of cellular DNA.

[1]  J. Bishop,et al.  Site-specific mutagenesis of avian erythroblastosis virus: erb-B is required for oncogenicity. , 1983, Virology.

[2]  J. Coffin,et al.  Efficient packaging of readthrough RNA in ALV: implications for oncogene transduction. , 1987, Science.

[3]  H. Varmus,et al.  Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Hay,et al.  The role of RNA molecules in transduction of the proto-oncogene c-fps , 1986, Cell.

[5]  V. Pathak,et al.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Coffin,et al.  Polyadenylation at correct sites in genome RNA is not required for retrovirus replication or genome encapsidation , 1989, Journal of virology.

[7]  M. Lai,et al.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail , 1977, Cell.

[8]  J. Mullins,et al.  Structure, origin, and transforming activity of feline leukemia virus-myc recombinant provirus FTT , 1989, Journal of virology.

[9]  H. Kung,et al.  Mechanism of c-erbB transduction: newly released transducing viruses retain poly(A) tracts of erbB transcripts and encode C-terminally intact erbB proteins , 1988, Journal of virology.

[10]  D. Baltimore,et al.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase , 1981, Journal of virology.

[11]  A. Bernstein,et al.  RNA tumor viruses , 1982 .

[12]  P Berg,et al.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.

[13]  W. Gilbert,et al.  Nucleotide sequence of rous sarcoma virus , 1983, Cell.

[14]  J. Coffin,et al.  Differential transcription from the long terminal repeats of integrated avian leukosis virus DNA , 1986, Journal of virology.

[15]  V. Pathak,et al.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Moore,et al.  Electrophoretic separation of polyadenylation-specific complexes. , 1987, Genes & development.

[17]  R. Weinberg,et al.  Generation of novel, biologically active Harvey sarcoma viruses via apparent illegitimate recombination , 1981, Journal of virology.

[18]  J. Bishop Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.